U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: LQDA) | Delayed: 38.86 +2.51 (6.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.35 | 52 Week High | $ | |||
| Open | $36.65 | 52 Week Low | $ | |||
| Day High | $39.20 | P/E | N/A | |||
| Day Low | $36.51 | EPS | $ | |||
| Volume | 3,883,337 | |||||
